Cassava Sciences Inc financial data

Symbol
SAVA on Nasdaq
Industry
Pharmaceutical Preparations
Location
6801 N Capital Of Texas Highway, Building 1; Suite 300, Austin, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
PAIN THERAPEUTICS INC (to 3/25/2019)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 339 % -73.9%
Debt-to-equity 9.41 % +159%
Return On Assets -9.12 % +80.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.1M shares +14.1%
Common Stock, Shares, Outstanding 48M shares +13.9%
Entity Public Float 967M USD -12.1%
Common Stock, Value, Issued 48K USD +14.3%
Weighted Average Number of Shares Outstanding, Basic 48M shares +14.2%
Weighted Average Number of Shares Outstanding, Diluted 48M shares +14.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 67.8M USD -25.1%
General and Administrative Expense 66.9M USD +325%
Operating Income (Loss) -135M USD -29.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -17.7M USD +81.5%
Earnings Per Share, Basic -0.37 USD/shares +4.92%
Earnings Per Share, Diluted -0.58 USD/shares +4.92%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 149M USD +4.66%
Other Assets, Current 192K USD +1.59%
Assets, Current 203M USD +34.9%
Property, Plant and Equipment, Net 21.1M USD -4.27%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 69K USD -74.3%
Assets 224M USD +29.7%
Accounts Payable, Current 10.3M USD +117%
Employee-related Liabilities, Current 1.95M USD +943%
Accrued Liabilities, Current 7.04M USD +112%
Liabilities, Current 57M USD +228%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 80K USD
Liabilities 57.1M USD +228%
Retained Earnings (Accumulated Deficit) -378M USD -4.91%
Stockholders' Equity Attributable to Parent 167M USD +7.43%
Liabilities and Equity 224M USD +29.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.1M USD -44.3%
Net Cash Provided by (Used in) Financing Activities 22.2M USD +34525%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 48M shares +13.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 189M USD +32.8%
Deferred Tax Assets, Valuation Allowance 77.3M USD +43.2%
Deferred Tax Assets, Gross 77.3M USD +43.2%
Operating Lease, Liability 139K USD -41.1%
Depreciation 989K USD -9.1%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 143K USD -41.6%
Property, Plant and Equipment, Gross 24.1M USD +0.2%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 36K USD -66.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 107K USD +4.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4K USD -55.6%
Deferred Tax Assets, Operating Loss Carryforwards 33.3M USD +18.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.41M USD +29.5%
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 544M USD +5.67%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 238K USD -49.9%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 12.7M USD +312%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%